<DOC>
	<DOCNO>NCT02381301</DOCNO>
	<brief_summary>Coronary artery disease ( CAD ) lead cause morbidity mortality develop country . In addition , many patient suffer valvular aortic disease . Although various tool available identify patient cardiovascular ( CV ) disease risk major adverse cardiac event ( MACE ) , identification patient remain clinical challenge . One promising avenue use different serum biomarkers involve atherothrombosis could provide easy cost-effective step risk stratification .</brief_summary>
	<brief_title>Biomarkers Cardiac CT</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Patients refer Cardiology clinic routine CCTA . Pregnancy Severe renal insufficiency Severe allergy contrast medium Inability obtain informed consent Age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Biological Markers</keyword>
	<keyword>Multidetector Computed Tomography</keyword>
</DOC>